Tixel i, an FDA-cleared treatment, utilizes gentle Thermo-Mechanical Action® to apply heat and pressure directly to the meibomian glands, enhancing oil secretion and targeting the root cause of dry ...

Meibomian gland dysfunction (MGD) is a common eye condition, yet many people don't realize they have it. You get it when there's a problem with a few dozen tiny glands in your eyelids that help ...

Session ID: 2025-06-28:6aad94ffe1c9729b1419fab Player Element ID: V079f129d_d936_419b_a29b_506ddd10e535_6339974076112 ...

In a 2021 study of over 100 participants, researchers found that IPL therapy provided effective treatment for MGD, an underlying cause of dry eyes. It was found to clinically improve symptoms and ...

Label expansion for evaporative dry eye due to MGD will support further efforts to drive patient access to insurance-covered TearCare treatments MENLO PARK, Calif., Dec. 22, 2021 (GLOBE NEWSWIRE ...

One session of vectored thermal pulsation was more efficacious than a warm compress for treating dry eye disease, according to a study. The systematic review and meta-analysis consisted of 385 ...

Eyelid hygiene is recommended twice daily for patients. Eyelid cleanser, combined with diluted baby shampoo, reduced signs and symptoms of DED and MGD in a randomized, contralateral eye study.

A review published in Clinical Ophthalmology found that intense pulsed light (IPL) was an effective treatment for meibomian gland dysfunction (MGD) but required further research to prove its ...

Vittitow J, et al. In Vitro Inhibition of Evaporation with Perfluorohexyloctane, an Eye Drop for Dry Eye Disease. Curr Ther Res Clin Exp. 2023 May 12;98:100704. doi: 10.1016/j.curtheres.2023.100704.

Nance has spent thousands of dollars just on eye drops. She turns to them 10 to 15 times a day to make it through. "It's painful. It can be so painful," Nance said.

Hengrui’s Heng Qin® (Perfluorohexyloctane Eye Drops) Approved as First Treatment for Dry Eye Disease Associated with MGD Business Wire Tue, Jul 8, 2025, 8:00 AM6 min read ...